GW26-e1831 The predictable between CAl25 and the rehospitalization rate in CHF patients  by Ma, Rui
C212 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5(n¼67) according to altitude. The levels of Serum HMGB1, Fetuin-A
were measured by ELISE. Left ventricular ejection fraction (LVEF) by
echocardiography, LVMI and MWS were calculated.
RESULTS The level of Serum HMGB1 and LVMI, MWS in CHF patients
lived at high altitude were higher than those at moderate altitude
[(42.877.86) pg/ml vs (26.755.22) pg/ml, (189.79.5) vs (96.38.4)
g/m2 and (476.214.9) vs (304.713.5) dynes x103/cm2, respectively,
all p<0.01].and the level of Fetuin-A was on the contrary [(1.15 0.32)
g/L vs ( 2.38 0.56) g/L, p<0.01]. It was found that LVMI, MWS has a
positive correlation withthe level of HMGB1 (P<0.01), and a negative
correlation With the level of Fetuin-A (P<0.01).
CONCLUSIONS ventricular remodeling in CHF change With the alti-
tude level severely. The changes LVMI and MWS were more related to
higher level of HMGB1 and lower level of Fetuin-A. At high altitude,
increasing in the level of HMGB1 and decreasing in the level of Fetuin-
A play roles in pathophysiological and pathogenetic mechanism of
ventricular remodeling in CHF, and correlated with the severity de-
gree of ventricular remodeling in CHF.
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OBJECTIVES To investigate the relationship between bone mineral
density and left ventricular diastolic function in elderly hypertension
patients.
METHODS Retrospective analysis was performed in 1002 consecutive
hypertension patients, aged over 60, who were admitted to the sec-
ond afﬁliated hospital of Dalian Medical University from December
2013 to February 2015. Bone mineral density (BMD) was measured by
dual X-ray absorptiometry and detected results were shown by T
scores averaged for all four parts. All cases were divided into three
groups based on T scores: Normal bone mass group (n¼269): T-1.0;
Osteopenia group (n¼433): -2.5<T<-1.0; and Osteoporosis group
(n¼300): T-2.5. In order to evaluate the left ventricular diastolic
function in patients, the echocardiogram was used to measure the
early diastolic peak velocity (E) and late diastolic peak velocity (A) of
left ventricle, and then calculate the E/A ratio. E/A 1.0 represents left
ventricular diastolic dysfunction (LVDD), which can be used to assess
the changes in LVDD and to evaluate the relationship with BMD.
ANOVA was applied to analyze the mean of the E/A ratio and Chi-
square test was used to compare LVDD incidence among the indicated
three groups. All cases were divided into two groups based on E/A
ratio. Normal left ventricular diastolic function group (n¼506), E/
A>1;left ventricular diastolic dysfunction group (n¼496), E/A 1.0.
Chi-square test was used to compare abnormal incidence of BMD
between the two groups. Simple linear correlation was used to analyze
the correlation of E/A ratio with each factor. Multiple linear regression
analysis was applied to analyze the independent factors of E/A ratio.
P<0.05 was considered statistically signiﬁcant.
RESULTS 1.The incidence of LVDD of Osteoporosis group (56.3%) was
signiﬁcantly higher than that of Normal bone mass group (44.2%) as
well as Osteopenia group (48%) (p<0.05). And there was no signiﬁcant
difference between Osteopenia group and Normal bone mass group
(p>0.05). The abnormal incidence of BMD of LVDD group (76%) was
higher than normal left ventricular diastolic function group (p<0.05).
2. Reduced BMD of the femoral neck (r¼0.102, p¼0.001) and
increased total cholesterol (r¼-0.067, p¼0.035) both were recognized
as independent variables of LVDD in multinomial regression analysis.
CONCLUSIONS 1. The incidence of LVDD of Osteoporosis group is
signiﬁcantly higher than that of Normal bone mass group. The
abnormal incidence of BMD of LVDD in elderly hypertension patients
is higher than that of normal left ventricular diastolic function.
2. Reduced BMD of the femoral neck and increased total cholesterol
both are recognized as independent variables of LVDD, which can be
referred to be important predictive factors in assessment and evalu-
ation of cardiovascular events.
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OBJECTIVES To study the relationship between CA 1 25 and the
rehospitalization rate in CHF patients.METHODS 145 patients with CHF were divided into three groups
based on the standard of NYHA.classiﬁcation. The subgroup were
divided according CAl25 levels(35 U / m1) and BNP levels(400 pg / m1).
After 1-.6 months follow-up, the endpoints, mortality and CHF reho-
spitalization were analyzed according the level of CAl25 and BNP.
RESULTS The higher the SeDlm of CAl25, the higher NYHA functional
class[I / 1I(18. 795. 23)U / ml, llI(82. 34_þ24. 37)U / ml, IV(187, 4037.
42)U / ml, P<O. 05], the rate of rehospitalization in patients with CHF
was higher with the increase of selxlm CAl25(P20. 01 1) and BNP(P20.
001). The combination CAl25 with BNP showed more accurately pre-
dictable value of CHF rehospitalization(P¼O. 00012).
CONCLUSIONS Serum levels of CAl25 are associated with the severity
of CHF, which can prognosis the rehospitalization in CHF patients.
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OBJECTIVES Pulmonary hypertension (PH) secondary to left ven-
tricular systolic dysfunction (LVSD) is often a poor prognosis marker
in chronic heart failure. Diastolic ﬁlling pressure abnormalities have
been described in patients with severe PH. The aim of our study was
to assess between diastolic function and PH associated LVSD.
METHODS 425 patients with LV Ejection fraction(EF) 40% were
divided into two groups according to the PH. PH estimated with the
right ventricular systolic pressure. PH was deﬁned systolic pulmonary
artery pressure (PAP) > 45 mmHg at rest. Diastolic parameters
(transmitral ﬂow velocity (E)/mitral annular velocity (e0), mitral valve
deceleration time (DT) and left atrium diameter (LAD) were evaluated.
RESULTS 135 patients had PH, whereas 290 patients had normal. Pa-
tients with PH were with higher E/e0 ratio, lower DT and increased
LAD. In multiple regression analysis, PAP was signiﬁcantly correlated
with E/e0 ratio, DT, gender and LAD. In multivariate analysis, E/e0
ratio> 15(odds ratio: 3.5, P<0.001), LAD (>4.2 cm in male, >3.8 cm in
female) (odds ratio: 2.2, P<0.001), female (odds ratio: 2.1, P¼0.003)
were the independent risk factors for PH in patients with LVSD.
CONCLUSIONS The diastolic echocardiographic parameters may be
important predictors for PH in patients with LVSD.
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OBJECTIVES To aim at investigating serum C-reactive protein (CRP),
a marker of systemic inﬂammation, its role as a prognostic marker in
patients with chronic heart failure (CHF).
METHODS We searched Medline and EMBASE for prospective studies
of patients with CHF that reported clinical outcomes according to
serum CRP levels. A meta-analysis was performed to assess the as-
sociation between CRP levels and prognoses in patients with CHF.
RESULTS A total of eight studies involving 6018 patients were
included in our study. Mean level of CRP was 3.27mg/L at baseline.
Long term follow-up varied from 1 year to 8.7 years. Our pooled re-
sults demonstrated that a high level of CRP was a predictor of mor-
tality (Hazard ratio: 1.86; 95% CI: 1.33 to 3.59; P<0.001) and major
adverse cardiac events (MACE) (Hazard ratio: 2.87, 95% CI: 1.64 to
4.62; P<0.001) in multivariate analysis.
CONCLUSIONS Levels of CRP have predictive value in long term
mortality and MACE of patients with CHF.
GW26-e2458
Efﬁcacy of Recombinant Human Brain Natriuretic Peptide in acute
decompensated ischemic heart failure
Zhijun Zhu, Danning Wu
The ll7th Hospital of PLA
OBJECTIVES To explore the clinical efﬁcacies of recombinant human
brain natriuretic peptide(rhBNP) in patients with acute decom-
pensated ischemic heart failure.
